Shepherd FA - Search Results

1

Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome.

Shepherd FA, Douillard JY, Blumenschein GR Jr. Shepherd FA, et al. J Thorac Oncol. 2011 Oct;6(10):1763-73. doi: 10.1097/JTO.0b013e31822e28fc. J Thorac Oncol. 2011. PMID: 21876456 Free article. Review.

2

Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.

Leighl NB, Shepherd FA, Kwong R, Burkes RL, Feld R, Goodwin PJ. Leighl NB, et al. Among authors: shepherd fa. J Clin Oncol. 2002 Mar 1;20(5):1344-52. doi: 10.1200/JCO.2002.20.5.1344. J Clin Oncol. 2002. PMID: 11870178

3

Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, Liu N, Lu C, Woodgett J, Seiden I, Johnston M, Keshavjee S, Darling G, Winton T, Breitkreutz BJ, Jorgenson P, Tyers M, Shepherd FA, Tsao MS. Wigle DA, et al. Among authors: shepherd fa. Cancer Res. 2002 Jun 1;62(11):3005-8. Cancer Res. 2002. PMID: 12036904

4

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Among authors: shepherd fa. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

5

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.

Shepherd FA, Giaccone G, Seymour L, Debruyne C, Bezjak A, Hirsh V, Smylie M, Rubin S, Martins H, Lamont A, Krzakowski M, Sadura A, Zee B. Shepherd FA, et al. J Clin Oncol. 2002 Nov 15;20(22):4434-9. doi: 10.1200/JCO.2002.02.108. J Clin Oncol. 2002. PMID: 12431965 Clinical Trial.

6

Pemetrexed in the treatment of non-small cell lung cancer.

Shepherd FA. Shepherd FA. Semin Oncol. 2002 Dec;29(6 Suppl 18):43-8. doi: 10.1053/sonc.2002.37470. Semin Oncol. 2002. PMID: 12571810 Review.

7

Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.

Blackhall FH, Pintilie M, Michael M, Leighl N, Feld R, Tsao MS, Shepherd FA. Blackhall FH, et al. Among authors: shepherd fa. Clin Cancer Res. 2003 Jun;9(6):2241-7. Clin Cancer Res. 2003. PMID: 12796392

8

Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer.

Sridhar SS, Seymour L, Shepherd FA. Sridhar SS, et al. Among authors: shepherd fa. Lancet Oncol. 2003 Jul;4(7):397-406. doi: 10.1016/s1470-2045(03)01137-9. Lancet Oncol. 2003. PMID: 12850190 Review.

9

Angiogenesis inhibitors under study for the treatment of lung cancer.

Shepherd FA, Sridhar SS. Shepherd FA, et al. Lung Cancer. 2003 Aug;41 Suppl 1:S63-72. doi: 10.1016/s0169-5002(03)00144-2. Lung Cancer. 2003. PMID: 12867064 Review.

10

Second-line chemotherapy for non-small cell lung cancer.

Shepherd FA. Shepherd FA. Expert Rev Anticancer Ther. 2003 Aug;3(4):435-42. doi: 10.1586/14737140.3.4.435. Expert Rev Anticancer Ther. 2003. PMID: 12934656 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters